Home > Insider Trading > Filing (0000904454-13-001014)

Filing Details

Accession Number:: 0000904454-13-001014
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-09-17 10:53:52
Reporting Period:: 2013-09-16

Filing Date:: 2013-09-17
Accepted Time:: 2013-09-17 10:53:52
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1369786	Sagent Pharmaceuticals Inc.	SGNT	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1227255	Frank Kung	C/O Sagent Pharmaceuticals, Inc. 1901 North Roselle Road, Suite 700 Schaumburg IL 60195		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2013-09-16	539,017	$21.25	3,618,946	No	4	S	Indirect	See footnote
Common Stock	Disposition	2013-09-16	622,700	$21.25	4,180,791	No	4	S	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See footnote
No	4	S	Indirect	See footnote

Footnotes

In connection with the Issuer's registered offering (the "Offering"), Vivo Ventures Fund V, L.P. ("Fund V") and Vivo Ventures V Affiliates Fund, L.P. ("V Affiliates Fund") sold 532,765 and 6,252 shares of the Issuer's common stock ("Common Stock"), respectively, pursuant to an underwriting agreement, dated September 10, 2013 by and among the Issuer, the underwriters and the selling stockholders party thereto (the "Underwriting Agreement")
In connection with the Offering, Vivo Ventures Fund VI, L.P. ("Fund VI") and Vivo Ventures VI Affiliates Fund, L.P. ("VI Affiliates Fund") sold 618,171 and 4,529 shares of Common Stock, respectively, pursuant to the Underwriting Agreement.
Immediately following the consummation of the Offering, Fund V and V Affiliates Fund owns an aggregate of 3,576,966 and 41,980 shares of Common Stock, respectively. Dr. Kung is the managing partner of Vivo Ventures V, LLC, the sole general partner of Fund V and V Affiliates Fund. As a result, Dr. Kung may be deemed to be the beneficial owner of the shares held by Fund V and V Affiliates Fund. Dr. Kung hereby disclaims any beneficial ownership of any shares directly held by Fund V and V Affiliates Fund, except to the extent of its pecuniary interest therein.
Immediately following the consummation of the Offering, Fund VI and VI Affiliates Fund owns an aggregate of 4,150,386 and 30,405 shares of Common Stock, respectively. Dr. Kung is the managing partner of Vivo Ventures VI, LLC, the sole general partner of Fund VI and VI Affiliates Fund. As a result, Dr. Kung may be deemed to be the beneficial owner of the shares held by Fund VI and VI Affiliates Fund. Dr. Kung hereby disclaims any beneficial ownership of any shares directly held by Fund VI and VI Affiliates Fund, except to the extent of its pecuniary interest therein.